About Rapid Diagnostics

Rapid diagnostic tests are diagnostic assays designed for low-resource settings that provide faster results. These can be carried out either at a patient's bedside or in a clinical setting. These devices are simple to operate and read, have a low cost, and are specific, sensitive, and stable at extreme temperatures. They also provide quick results. Rapid diagnostics is the fastest-growing segment in in vitro diagnostics (IVD). Rapid diagnostic tests include agglutination, lateral flow, flow through, solid phase, and nucleic-acid amplification tests. Diagnostic devices are used to detect and measure blood glucose and coagulation levels, cardiac biomarkers, infectious diseases, hemoglobin concentration, five-part differential blood count, and pregnancy and fertility status. These tests can be used at patient's bedside, and in physician's clinics, ICUs, operating rooms, emergency rooms, and inpatient wards. The healthcare professional attending to the patient obtains the specimen, performs an analysis, and records the result.

Technavio’s analysts forecast the global rapid diagnostics market to grow at a CAGR of 7.27% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global rapid diagnostics market for 2016-2020. To calculate the market size, revenue generated from the sales of rapid diagnostics products, including over-the-counter (OTC) rapid diagnostics tests (self-testing kits, glucose meters, and strips) and professional rapid diagnostics tests (test kits, handheld devices, and small analyser) have been considered.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Rapid Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Alere Inc.
• Beckman Coulter Inc.
• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthcare

Other prominent vendors
• Abaxis
• Accriva Diagnostics
• ACON Laboratories
• A. Menarini Diagnostics
• Bayer HealthCare
• BD
• Bio-AMD
• Bio-Rad Laboratories
• Cepheid
• Chembio Diagnostic Systems
• Clarity Diagnostics
• DiagCor Bioscience
• Diasorin
• Eiken Chemical
• GlySens
• Helena Laboratories
• Hemosure
• Hologic
• Humor Diagnostica
• LifeScan
• Meridian Life Sciences
• Nipro Diagnostics
• Oasis Diagnostics
• OPKO Health
• OraSure Technologies
• Quidel
• Randox Laboratories
• Sysmex
• Trinity Biotech
• Trivitron Healthcare
• URIT

Market driver
• Increase in incidence of chronic and infectious diseases
• For a full, detailed list, view our report

Market challenge
• Pricing pressures
• For a full, detailed list, view our report

Market trend
• Use of digital platforms in rapid diagnostics
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.